HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Voltage-dependent actions of short-chain polymethylene bis-trimethylammonium compounds on sympathetic ganglion neurons.

Abstract
Effects of polymethylene bis-trimethylammonium compounds (with 4-7 carbons in the polymethylene chain, C4-C7) on voltage-dependence of fast excitatory postsynaptic current (EPSC) were studied in voltage-clamped neurons of the isolated rabbit superior cervical ganglion. All these compounds shortened the EPSC decay (which remained single-exponential) and decreased (or reversed) the dependence of the EPSC decay on membrane hyperpolarization. All drugs slightly decreased the EPSC amplitude; in addition, C6 and C7 decreased their dependence on membrane hyperpolarization. It is suggested that shortening of the EPSC decay produced by ganglion-blocking agents results from their binding to the open ionic channel (channel-blocking effect). The ratio of channel-blocking activities of these drugs correlates with the well-known ratio of their ganglion-blocking activities. It is suggested that the channel-blocking activities of polymethylene bis-trimethylammonium compounds determine their ganglion-blocking activities. The model of channel-blocking action is discussed.
AuthorsA A Selyanko, V A Derkach, V I Skok
JournalJournal of the autonomic nervous system (J Auton Nerv Syst) Vol. 6 Issue 1 Pg. 13-21 (Jul 1982) ISSN: 0165-1838 [Print] Netherlands
PMID6290558 (Publication Type: Journal Article)
Chemical References
  • Bis-Trimethylammonium Compounds
  • Hexamethonium Compounds
  • Receptors, Cholinergic
Topics
  • Animals
  • Bis-Trimethylammonium Compounds (pharmacology)
  • Evoked Potentials (drug effects)
  • Ganglia, Sympathetic (drug effects)
  • Hexamethonium Compounds (pharmacology)
  • Kinetics
  • Models, Neurological
  • Neurons (drug effects)
  • Rabbits
  • Receptors, Cholinergic (drug effects)
  • Synapses (drug effects)
  • Synaptic Transmission (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: